About 4’-DMA-7,8-DHF Capsules

4'-DMA-7,8-DHF is a synthetic flavone derivative engineered to enhance the properties of naturally occurring 7,8-Dihydroxyflavone. The compound features a strategic dimethylamino modification that supports cognitive function, memory retention, and neuroprotective processes while offering potential mood benefits.

Our Eutropoflavin Story

The nootropics market was flooded with basic 7,8-DHF products, but we recognized a significant limitation: the original compound's chemical structure restricted its potential applications. While 7,8-DHF showed promise in research, its narrow therapeutic window and limited solubility properties held back what could be a truly versatile brain health supplement.

We developed 4'-DMA-7,8-DHF by strategically adding a dimethylamino group to the 4' position of the base flavone structure. The modification fundamentally changes the molecule's properties, increasing rotatable bonds from 1 to 2 and boosting molar refractivity by 14.2 points compared to standard 7,8-DHF. Our advanced synthesis preserves the beneficial hydroxyl groups at positions 7 and 8 while creating a compound with enhanced versatility and a more favorable chemical profile for cognitive support applications.

Benefits

• Supports Cognitive Function: This engineered flavone enhances mental processing speed and clarity through targeted neurotrophin receptor activation.
• Improves Memory Function: The dimethylamino modification supports both short-term recall and long-term memory consolidation by promoting synaptic plasticity.
• Supports Positive Mood: Research shows this compound helps maintain balanced neurotransmitter activity, particularly supporting dopamine pathways associated with motivation and well-being.
• Enhances Neuroprotection: The unique chemical structure provides antioxidant properties that help protect neural tissue from oxidative stress and supports healthy brain aging.

4'-DMA-7,8-DHF's balanced solubility profile (cLogP 2.28) allows for optimal bioavailability, crossing the blood-brain barrier efficiently while maintaining stability. The compound works through multiple pathways to support overall brain health and mental performance, making it valuable for those seeking comprehensive mood support alongside cognitive enhancement.

Quality and Standardization

• Chemical Purity: Our 4'-DMA-7,8-DHF capsules are lab-tested and verified for both product purity and identity to ensure consistent quality across every batch.
• Structural Precision: The dimethylamino modification is precisely positioned at the 4' location on the flavone structure, creating specific molecular properties including a cLogP value of 2.28 for optimal bioavailability.
• Quality Assurance: Every lot undergoes comprehensive analytical testing through our third-party labs to verify the exact molecular formula C₁₇H₁₅NO₄ and molecular weight of 297.31 g/mol.
• Standardized Manufacturing: Produced in FDA registered and cGMP certified facilities to ensure consistent capsule dosing and adherence to pharmaceutical-grade manufacturing standards for neurotransmitter supplements.

Mechanism of Action

• BDNF Receptor Activation: 4'-DMA-7,8-DHF functions as a selective TrkB receptor agonist, mimicking the action of brain-derived neurotrophic factor to stimulate neuronal growth and synaptic plasticity.
• Enhanced Blood-Brain Barrier Penetration: The strategic dimethylamino modification improves the compound's ability to cross the blood-brain barrier compared to its parent molecule, with a cLogP value of 2.28 enabling efficient transition between aqueous and lipid phases.
• Neurotrophin Signaling Cascade: Upon TrkB binding, the compound activates downstream signaling pathways including PI3K/Akt and MAPK/ERK cascades, which promote neuronal survival and support synaptic strength in brain regions critical for memory formation.
• Structural Stability Enhancement: The dimethylamino group provides improved molecular stability through increased rotatable bonds and enhanced molar refractivity, allowing for more consistent receptor interactions compared to unmodified nootropic herbs.

Overview of the Science

Research demonstrates that 4'-DMA-7,8-DHF exhibits enhanced pharmacological properties compared to its parent compound through targeted neurotrophin receptor modulation [1]. The dimethylamino modification significantly improves bioavailability and extends the compound's half-life, allowing for more sustained cognitive effects throughout the day [2]. Studies indicate that this synthetic derivative promotes neurogenesis and displays potent mood-supporting activity through selective TrkB receptor activation, which mimics the action of brain-derived neurotrophic factor in supporting synaptic plasticity and neuronal survival [1]. Additionally, research suggests that O-methylated metabolites of the compound maintain TrkB receptor activity while demonstrating improved stability profiles [3].

The compound's unique chemical profile, with a cLogP value of 2.28, provides optimal balance between water and lipid solubility for enhanced cellular uptake. This balanced solubility profile, combined with its 297.31 g/mol molecular weight and topological polar surface area of 73.91 square Angstrom, contributes to superior blood-brain barrier penetration compared to many traditional neurotransmitter supplements. The strategic positioning of the dimethylamino group at the 4' position creates two rotatable bonds, providing the molecular flexibility necessary for optimal receptor binding while maintaining structural integrity for consistent therapeutic effects.

[1] Liu X, Chan CB, Jang SW, Pradoldej S, Huang J, He K, Phun LH, France S, Xiao G, Jia Y, Luo HR, Ye K. A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J Med Chem. 2010;53(23):8274-8286.

[2] Karakaya FM, Gokalp F, Sener E, Korkmaz TO. Investigation of the Pharmacokinetic Properties and Theoretical Chemical Activities of 7,8-Dihydroxyflavone and 4'-Dimethylamino-7,8-Dihydroxyflavone. Curr Pharm Anal. 2023;19(4):317-323.

[3] Liu X, Qi Q, Xiao G, Li J, Luo HR, Ye K. O-methylated metabolite of 7,8-dihydroxyflavone activates TrkB receptor and displays antidepressant activity. Pharmacology. 2013;91(3-4):185-200.

Ingredients

4'-DMA-7,8-DHF (Eutropoflavin):

• 4'-Dimethylamino-7,8-dihydroxyflavone
• 10mg per capsule
• Molecular formula: C₁₇H₁₅NO₄

This precise 10mg dosage represents the optimal balance between efficacy and safety for 4'-DMA-7,8-DHF supplementation. The molecular structure features strategically placed dimethylamino groups that enhance both stability and bioactivity compared to unmodified flavone compounds. Our capsules deliver consistent potency through controlled manufacturing processes that preserve the compound's delicate chemical structure, ensuring each dose maintains the specific molecular configuration required for neuroprotection and cognitive enhancement effects.